Evidence map›Paper›PMID 40033301›Full record

ArticleCell communication and signaling : CCS2025

Sos1 ablation alters focal adhesion dynamics and increases Mmp2/9-dependent gelatinase activity in primary mouse embryonic fibroblasts.

Pilar Liceras-Boillos, Rósula Garcia-Navas, Clara Llorente-González, L Francisco Lorenzo-Martin, Luis Luna-Ramírez, Rocío Fuentes-Mateos, Nuria Calzada, Francisco M Vega, Mark R Holt, Anne J Ridley and 4 more

Abstract read
In one paragraph

Article in Cell communication and signaling : CCS, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Pilar Liceras-Boillos *Lab 1, Centro de Investigación del Cáncer - IBMCC (CSIC-USAL) and CIBERONC, Universidad de Salamanca, Salamanca, 37007, Spain.
Rósula Garcia-Navas *Lab 1, Centro de Investigación del Cáncer - IBMCC (CSIC-USAL) and CIBERONC, Universidad de Salamanca, Salamanca, 37007, Spain.
Clara Llorente-GonzálezMolecular Mechanisms Program, Centro de Investigación del Cáncer, Instituto de Biología Molecular y Celular del Cáncer, Consejo Superior de Investigaciones Científicas (CSIC) and University of Salamanca, Salamanca, 37007, Spain.
L Francisco Lorenzo-MartinEcole Polytechnique fédérale de Lausanne, Lausanne, Switzerland.
Luis Luna-RamírezDepartamento de Fisiología Medica y Biofísica, Facultad de Medicina, Universidad de Sevilla and Instituto de Biomedicina de Sevilla (IBiS) (Hospital Universitario Virgen del Rocío, CSIC/Universidad de Sevilla), Sevilla, 41013, Spain.
Rocío Fuentes-MateosLab 1, Centro de Investigación del Cáncer - IBMCC (CSIC-USAL) and CIBERONC, Universidad de Salamanca, Salamanca, 37007, Spain.
Nuria CalzadaLab 1, Centro de Investigación del Cáncer - IBMCC (CSIC-USAL) and CIBERONC, Universidad de Salamanca, Salamanca, 37007, Spain.
Francisco M VegaDepartamento de Biología Celular, Facultad de Biología, Universidad de Sevilla and Instituto de Biomedicina de Sevilla (IBiS) (Hospital Universitario Virgen del Rocío, CSIC/Universidad de Sevilla), Sevilla, 41012, Spain.
Mark R HoltRandall Centre of Cell and Molecular Biophysics, King's College London, Guy's Campus, New Hunt's House, London, SE1 1UL, UK.
Anne J RidleySchool of Cellular and Molecular Medicine, Biomedical Sciences Building, University Walk, University of Bristol, Bristol, BS8 1TD, UK.
Xose R BusteloLab 2, Centro de Investigación del Cáncer - IBMCC (CSIC-USAL) and CIBERONC, Universidad de Salamanca, Salamanca, 37007, Spain.
Miguel Vicente-ManzanaresMolecular Mechanisms Program, Centro de Investigación del Cáncer, Instituto de Biología Molecular y Celular del Cáncer, Consejo Superior de Investigaciones Científicas (CSIC) and University of Salamanca, Salamanca, 37007, Spain.
Eugenio SantosLab 1, Centro de Investigación del Cáncer - IBMCC (CSIC-USAL) and CIBERONC, Universidad de Salamanca, Salamanca, 37007, Spain. esantos@usal.es.
Fernando C BaltanásLab 1, Centro de Investigación del Cáncer - IBMCC (CSIC-USAL) and CIBERONC, Universidad de Salamanca, Salamanca, 37007, Spain. fcalvo@us.es.

Funding

Cancer Research UK C6620/A15961Consejería de Educación, Junta de Castilla y León CLU-2023-2-01Federación Española de Enfermedades Raras AI-2023-015Fundación Científica Asociación Española Contra el Cáncer EPAEC222641CICSFundación Ramón Areces CIVP19A5942Fundacion Samuel Solorzano Barruso FS/32-2020Instituto de Salud Carlos III FIS PI19/00934Junta de Castilla y León CLC-2017-01'la Caixa' Foundation HR20-00164Ministerio de Ciencia e Innovación MCIN/AEI/10.13039/501100011033/Ministerio de Ciencia e Innovación PID2020-116232RB-I00Ministerio de Ciencia e Innovación PID2022-136409OB-I00
6 · The paper itself

Abstract

backgroundSos1 and Sos2 are guanine-nucleotide exchange factors for Ras and Rac small GTPases, which are involved in a wide range of cellular responses including proliferation and migration. We have previously shown that Sos1 and Sos2 have different effects on cell migration, but the underlying mechanisms are not clear.

methodsUsing a 4-hydroxytamoxifen-inducible conditional Sos1

resultsFunctional analysis of the transcriptome of primary Sos1/2

conclusionsOur data demonstrate that Sos1 and Sos2 have different functions in FAs distribution and dynamics in 2D whereas in 3D they act together to regulate invasion and unveil a previously undescribed mechanistic connection between Sos1/2 and the regulation of Mmp2/9 expression in primary MEFs.

Indexed as

Embryo, MammalianFibroblastsFocal AdhesionsMatrix Metalloproteinase 2Matrix Metalloproteinase 9Son of Sevenless ProteinsSOS1 ProteinAnimalsCell MovementCells, CulturedMiceMice, KnockoutMatrix Metalloproteinase 2Matrix Metalloproteinase 9Son of Sevenless ProteinsSOS1 ProteinSos2 protein, mouseMigrationMmp2/9RacRasRasGEFSos1Sos2

Identifiers

PMID40033301
PMCPMC11874121

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.